National class action approved for users of this antipsychotic drug
The companies behind a drug that was recently approved to treat symptoms of agitation in Alzheimer's patients are facing a class-action lawsuit over alleged 'harmful side effects.'
![National class action approved for users of this antipsychotic drug](https://globalnews.ca/wp-content/uploads/2024/03/antipsychotic-drug-class-action.jpg?quality=85&strip=all#)
The companies behind a drug that was recently approved to treat symptoms of agitation in Alzheimer's patients are facing a class-action lawsuit over alleged 'harmful side effects.'